Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Forrest

Showing results (131-140 of 177) with videos related to

Pageof 18
Sort By:
Antimicrobial Agents and Chemotherapy|September 14, 2011
Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic modelPhillip J Bergen, Brian T Tsuji, Jurgen B Bulitta, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2009
Pharmacokinetic and pharmacodynamic evaluation of liposomal amikacin for inhalation in cystic fibrosis patients with chronic pseudomonal infectionOlanrewaju O Okusanya, Sujata M Bhavnani, Jeffrey Hammel, et al.
Antimicrobial Agents and Chemotherapy|January 6, 2016
Combinatorial Pharmacodynamics of Ceftolozane-Tazobactam against Genotypically Defined β-Lactamase-Producing Escherichia coli: Insights into the Pharmacokinetics/Pharmacodynamics of β-Lactam-β-Lactamase Inhibitor CombinationsRachel L Soon, Justin R Lenhard, Zackery P Bulman, et al.
Antimicrobial Agents and Chemotherapy|March 10, 2010
Attenuation of colistin bactericidal activity by high inoculum of Pseudomonas aeruginosa characterized by a new mechanism-based population pharmacodynamic modelJürgen B Bulitta, Jenny C Yang, Liliana Yohonn, et al.
International Journal of Antimicrobial Agents|December 10, 2016
In vitro pharmacodynamic evaluation of ceftolozane/tazobactam against β-lactamase-producing Escherichia coli in a hollow-fibre infection modelRachel L Soon, Justin R Lenhard, Zackery P Bulman, et al.
Journal of Pharmaceutical Sciences|October 25, 2023
Distinguishing Inducible and Non-Inducible Resistance to Colistin in Pseudomonas aeruginosa by Quantitative and Systems Pharmacology Modeling at Low and Standard InoculaJürgen B Bulitta, Eunjeong Shin, Phillip J Bergen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 27, 2015
Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?Roger L Nation, Samira M Garonzik, Jian Li, et al.
Pharmaceutical Research|June 13, 2012
Physiologically based pharmacokinetic model for composite nanodevices: effect of charge and size on in vivo dispositionDonald E Mager, Vidhi Mody, Chao Xu, et al.
Cytokine|December 5, 2016
Insulin use, adipokine profiles and breast cancer prognosisZachary A P Wintrob, Jeffrey P Hammel, Thaer Khoury, et al.
Antimicrobial Agents and Chemotherapy|April 25, 2012
Front-loaded linezolid regimens result in increased killing and suppression of the accessory gene regulator system of Staphylococcus aureusBrian T Tsuji, Tanya Brown, Ridhi Parasrampuria, et al.
Pageof 18

Showing results (131-140 of 177) with videos related to

Sort By:
Pageof 18
Antimicrobial Agents and Chemotherapy|September 14, 2011
Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic modelPhillip J Bergen, Brian T Tsuji, Jurgen B Bulitta, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2009
Pharmacokinetic and pharmacodynamic evaluation of liposomal amikacin for inhalation in cystic fibrosis patients with chronic pseudomonal infectionOlanrewaju O Okusanya, Sujata M Bhavnani, Jeffrey Hammel, et al.
Antimicrobial Agents and Chemotherapy|January 6, 2016
Combinatorial Pharmacodynamics of Ceftolozane-Tazobactam against Genotypically Defined β-Lactamase-Producing Escherichia coli: Insights into the Pharmacokinetics/Pharmacodynamics of β-Lactam-β-Lactamase Inhibitor CombinationsRachel L Soon, Justin R Lenhard, Zackery P Bulman, et al.
Antimicrobial Agents and Chemotherapy|March 10, 2010
Attenuation of colistin bactericidal activity by high inoculum of Pseudomonas aeruginosa characterized by a new mechanism-based population pharmacodynamic modelJürgen B Bulitta, Jenny C Yang, Liliana Yohonn, et al.
International Journal of Antimicrobial Agents|December 10, 2016
In vitro pharmacodynamic evaluation of ceftolozane/tazobactam against β-lactamase-producing Escherichia coli in a hollow-fibre infection modelRachel L Soon, Justin R Lenhard, Zackery P Bulman, et al.
Journal of Pharmaceutical Sciences|October 25, 2023
Distinguishing Inducible and Non-Inducible Resistance to Colistin in Pseudomonas aeruginosa by Quantitative and Systems Pharmacology Modeling at Low and Standard InoculaJürgen B Bulitta, Eunjeong Shin, Phillip J Bergen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 27, 2015
Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?Roger L Nation, Samira M Garonzik, Jian Li, et al.
Pharmaceutical Research|June 13, 2012
Physiologically based pharmacokinetic model for composite nanodevices: effect of charge and size on in vivo dispositionDonald E Mager, Vidhi Mody, Chao Xu, et al.
Cytokine|December 5, 2016
Insulin use, adipokine profiles and breast cancer prognosisZachary A P Wintrob, Jeffrey P Hammel, Thaer Khoury, et al.
Antimicrobial Agents and Chemotherapy|April 25, 2012
Front-loaded linezolid regimens result in increased killing and suppression of the accessory gene regulator system of Staphylococcus aureusBrian T Tsuji, Tanya Brown, Ridhi Parasrampuria, et al.
Pageof 18